bexarotene has been researched along with pioglitazone in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 2 (33.33) | 2.80 |
Authors | Studies |
---|---|
Fujiwara, C; Furusawa, Y; Hagaya, M; Kakuta, H; Kawata, K; Kobayashi, T; Kohara, K; Makishima, M; Naitou, H; Nakayama, M; Ohsawa, F; Ohta, Y; Shinozaki, R; Tai, A; Yakushiji, N; Yamada, S; Yasui, H; Yoshikawa, Y | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Goduni, E; Jay, T; Lamb, BT; Landreth, GE; Malm, T; Mariani, MM; Quigley, C; Ransohoff, RM; Savage, JC | 1 |
Ba'th, F; Handley, N; Mathison, G; Nachbor, KM; Ondrey, FG; Rosas, RR; Wuertz, BR | 1 |
Carrasco, AG; Coward, RJ; Flores-Salguero, E; Izquierdo-Lahuerta, A; Medina-Gómez, G; Ni, L; Valverde, ÁM | 1 |
1 review(s) available for bexarotene and pioglitazone
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
5 other study(ies) available for bexarotene and pioglitazone
Article | Year |
---|---|
Mechanism of retinoid X receptor partial agonistic action of 1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)-1H-benzotriazole-5-carboxylic acid and structural development to increase potency.
Topics: Animals; Chlorocebus aethiops; COS Cells; Diabetes Mellitus, Type 2; Hypoglycemic Agents; Mice; Models, Molecular; Molecular Docking Simulation; Retinoid X Receptors; Tetrahydronaphthalenes; Triazoles | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Nuclear receptors license phagocytosis by trem2+ myeloid cells in mouse models of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Axl Receptor Tyrosine Kinase; Benzoates; Benzylamines; Bexarotene; c-Mer Tyrosine Kinase; Cells, Cultured; Disease Models, Animal; Gene Expression Regulation; Leukocyte Common Antigens; Macrophages; Male; Membrane Glycoproteins; Mice; Microglia; Myeloid Cells; Phagocytosis; Pioglitazone; Plaque, Amyloid; Proto-Oncogene Proteins; Receptor Protein-Tyrosine Kinases; Receptors, Cytoplasmic and Nuclear; Receptors, Immunologic; Tetrahydronaphthalenes; Thiazoles; Thiazolidinediones | 2015 |
Preclinical evidence for pioglitazone and bexarotene combination in oral cancer chemoprevention.
Topics: Bexarotene; Chemoprevention; Head and Neck Neoplasms; Humans; Mouth Neoplasms; Pioglitazone; United States | 2022 |
The protective role of peroxisome proliferator-activated receptor gamma in lipotoxic podocytes.
Topics: Bexarotene; Humans; Kidney Diseases; Pioglitazone; Podocytes; PPAR gamma; Thiazolidinediones | 2023 |